Preclinical News and Research

RSS
TxCell to highlight success factors in cell therapy research at Cell & Gene Therapy Forum 2015

TxCell to highlight success factors in cell therapy research at Cell & Gene Therapy Forum 2015

NCCS launches human clinical trial of new cancer vaccine

NCCS launches human clinical trial of new cancer vaccine

Neuroptis reports positive results from ML7 pre-clinical trial for treatment of dry eye syndrome

Neuroptis reports positive results from ML7 pre-clinical trial for treatment of dry eye syndrome

Researchers identify promising new target for developing better therapies for neuroblastoma kids

Researchers identify promising new target for developing better therapies for neuroblastoma kids

Researchers reveal key factor in understanding elevated cancer risk linked to gene therapy

Researchers reveal key factor in understanding elevated cancer risk linked to gene therapy

AMRI awarded NIH contract for drug development services

AMRI awarded NIH contract for drug development services

Findings may lead to novel therapeutic approaches to prevent fibrosis in Crohn's disease patients

Findings may lead to novel therapeutic approaches to prevent fibrosis in Crohn's disease patients

CTI Life Sciences announces closing of second venture capital fund

CTI Life Sciences announces closing of second venture capital fund

CAR T-cell therapy enters into Phase I clinical trial

CAR T-cell therapy enters into Phase I clinical trial

Crown's first European symposium to focus on use of Translational Platforms in oncology drug discovery

Crown's first European symposium to focus on use of Translational Platforms in oncology drug discovery

3SBio, PharmAbcine sign licensing agreement to develop and market DIG-KT

3SBio, PharmAbcine sign licensing agreement to develop and market DIG-KT

Researchers identify new target that could lead to potential therapies for GBM

Researchers identify new target that could lead to potential therapies for GBM

PF-114 shows promise in therapy-resistant CML, Ph-positive ALL

PF-114 shows promise in therapy-resistant CML, Ph-positive ALL

MGB Biopharma provides update on business performance for 2014

MGB Biopharma provides update on business performance for 2014

Crown Bioscience to double capacity of PRECOS facility, rename UK site

Crown Bioscience to double capacity of PRECOS facility, rename UK site

EMA recommends orphan designation to Magnus Growth's novel therapy for placental insufficiency

EMA recommends orphan designation to Magnus Growth's novel therapy for placental insufficiency

Arcturus to exhibit new mRNA therapeutics pipeline at two healthcare conferences

Arcturus to exhibit new mRNA therapeutics pipeline at two healthcare conferences

Novel drug delivery technique uses graphene to deliver two anticancer drugs sequentially to cancer cells

Novel drug delivery technique uses graphene to deliver two anticancer drugs sequentially to cancer cells

CytRx reports positive interim results from aldoxorubicin Phase 2 trial for treatment of GBM

CytRx reports positive interim results from aldoxorubicin Phase 2 trial for treatment of GBM

Johnson & Johnson begins Phase 1 trial of preventive Ebola vaccine program

Johnson & Johnson begins Phase 1 trial of preventive Ebola vaccine program

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.